A progressive movement disorder from loss of dopaminergic neurons in the substantia nigra. Increasingly understood as a gut-origin disease, alpha-synuclein aggregates may begin in the gut and travel via the vagus nerve. Microbiome health, mitochondrial support, and anti-inflammatory diet are core interventions.
Last updated:
Parkinson's disease is a progressive neurodegenerative disorder caused by the loss of dopamine-producing neurons in the substantia nigra of the brain. The classic motor symptoms, tremor, rigidity, bradykinesia (slow movement), postural instability, emerge after ~50-70% of these neurons have been lost.
Pathologically defined by accumulation of misfolded alpha-synuclein protein into "Lewy bodies." Increasingly understood as a multi-system disease that begins decades before motor symptoms, often in the gut and olfactory bulb. The "gut origin" hypothesis (Braak staging) proposes alpha-synuclein may travel via the vagus nerve from gut to brain.
Beyond movement, Parkinson's affects mood, cognition, autonomic function, sleep, and GI motility. Premotor symptoms (constipation, loss of smell, REM sleep behavior disorder) may precede tremor by 10-20 years, a critical window for prevention research.
Unilateral or bilateral mild motor symptoms. No balance impairment. Independent. "Honeymoon" period, medications work well. Aggressive intervention here matters most.
Severe disability, needs help with ADLs, eventually wheelchair/bed-bound. Cognitive decline common. Hallucinations may emerge. End-of-life planning important.
Motor symptoms are classic but non-motor symptoms often precede them by years. Recognize both.
"Pill-rolling" tremor at rest, usually starts in one hand. Disappears with action. Often the first noticed symptom. Asymmetric onset is characteristic.
Slowness of movement initiation and execution. Smaller handwriting (micrographia), reduced facial expression (hypomimia), softer voice (hypophonia).
Increased muscle tone; "cogwheel" rigidity on exam. Stiffness in limbs, neck. Often associated with discomfort or pain.
Shuffling steps, reduced arm swing, freezing of gait, falls. Later in disease. Falls are a major cause of morbidity.
May precede motor symptoms by 10-20 years. Slow gut transit. Critical to address, affects medication absorption and quality of life.
Reduced or absent sense of smell. May precede motor symptoms by 5-10 years. Olfactory bulb is one of first structures affected.
Acting out dreams, kicking, punching, falling out of bed. Very strong predictor, ~80% develop Parkinson's or related synucleinopathy within 10-15 years.
Depression in ~50%. Anxiety, apathy, cognitive slowing common. Dementia in ~30-40% of advanced disease (Lewy body dementia).
Diagnosis is primarily clinical, neurologist examines for cardinal features: bradykinesia + tremor or rigidity. Asymmetric onset supports diagnosis. MDS criteria.
Dramatic improvement with levodopa supports diagnosis (and is often used therapeutically as a diagnostic test). Poor response suggests atypical parkinsonism.
SPECT imaging of dopamine transporters in striatum. Distinguishes Parkinson's from essential tremor and drug-induced parkinsonism. Used when diagnosis unclear.
NEW: Detects misfolded alpha-synuclein in spinal fluid or skin biopsy. ~90% sensitive/specific. May enable earlier diagnosis and clinical trial enrollment.
COMPLEMENTS medications. Exercise is the single most powerful intervention, possibly disease-modifying.
Mediterranean/MIND diet + protein-redistribution + aggressive constipation management + coffee. Address gut-brain axis as core therapy.
Strong inverse association with Parkinson's risk. Caffeine may slow progression. Black or with minimal additions.
Combat constipation, support microbiome. Ground flax (1-2 tbsp/day), prunes, beans, vegetables, whole grains. Critical for medication absorption.
Omega-3 anti-inflammatory, neuroprotective. Wild salmon, sardines, mackerel.
EGCG neuroprotective; modulates alpha-synuclein aggregation in lab studies. 2-3 cups/day.
Vegetables, fruits, olive oil, nuts, fish, legumes. Strong inverse association with Parkinson's progression.
Don't restrict protein, but TIME it. Take levodopa 30-60 min BEFORE meals. Consider protein-redistribution, most protein at evening meal.
High dairy intake (especially low-fat dairy) associated with increased Parkinson's risk in epidemiologic studies. Moderate consumption fine.
Pro-inflammatory; worsen brain insulin resistance. Drive constipation. Eliminate sodas, sweets, white bread.
Pesticide exposure (paraquat, rotenone, organochlorines) associated with Parkinson's. Choose organic when possible, especially for "dirty dozen" produce.
Worsens falls risk, sleep, cognition. Interacts with PD medications. Light moderate use may be neutral but limit.
Best evidence: CoQ10, creatine, B vitamins, vitamin D, omega-3. Always coordinate with neurologist, interactions exist.
| Supplement | Mechanism & Evidence | Suggested Dose | Timing | Notes |
|---|---|---|---|---|
| Coenzyme Q10 (Ubiquinol) | Mitochondrial support; deficient in PD brains. Some studies show modest motor symptom slowing. | 300-600mg/day | With fat meal | Ubiquinol form (especially over 50) more bioavailable. |
| Vitamin D3 | Deficiency near-universal; correlates with worse motor symptoms. Supports neurons and bone health. | 2,000-5,000 IU/day (titrate to 50-80 ng/mL) | With fat meal | Pair with K2 200mcg. |
| Omega-3 (EPA/DHA) | Anti-inflammatory, supports neuronal membranes, may improve depression in PD. | 2,000-3,000mg EPA+DHA/day | With fat meal | Test omega-3 index. |
| Creatine | Mitochondrial energy support. Mixed evidence, large trial negative but may help in subgroups. | 5g/day | With meals | Well-tolerated. May enhance exercise benefits. |
| B-Complex (B12, Folate) | Deficiency common in PD (levodopa increases homocysteine). Critical for neuronal function. | B12 1,000mcg + Folate 800mcg/day | Morning | Methylated forms preferred. |
| Curcumin | Anti-inflammatory, anti-amyloid in lab. Modulates alpha-synuclein aggregation. | 500-1,500mg/day (bioavailable form) | With fat meal | Discuss with neurologist before starting. |
| Probiotics (Specific Strains) | Improve constipation; modulate gut-brain axis. L. acidophilus + B. infantis show benefit. | 10-30 billion CFU/day, multi-strain | With or without food | Consistent daily use needed for benefit. |
| Mucuna Pruriens (Velvet Bean) | Natural source of L-dopa. Used in Ayurveda. May have advantages over synthetic levodopa (additional compounds). | Variable, start with 200mg standardized to 15% L-dopa | Discuss with neurologist | CAUTION: Cannot be combined safely with synthetic levodopa without medical supervision. Discuss seriously with neurologist. |
Parkinson's responds to a comprehensive approach. Don't view exercise as optional, it may be your most powerful disease-modifying intervention. Address gut health, optimize medication timing, and partner with a movement disorder specialist. The earlier the integrated approach, the better the long-term outcomes.